Skip to content

OCRA Corporate Sponsors & Partners

Corporate Sponsors

We are deeply grateful to our past and current corporate partners for supporting our mission to find a cure and improve the lives of those affected by ovarian and other gynecologic cancers.

Corporate Partners

Conflict of Interest Statement — Industry Partners

  • Corporate partners including industry do not shape OCRA’s agenda, research, or advocacy.
  • In 2023, industry partners represented 8% of OCRA’s overall revenue.
  • If an industry partner sponsors an OCRA program, grant, or educational materials, it is publicly acknowledged and the supporting company has no editorial or strategic input.
  • Any reference to a specific commercial product or service does not constitute or imply an endorsement by OCRA of the product or service or its producer or provider. The views and opinions expressed in any referenced document or on any referenced website do not necessarily reflect those of OCRA.

Related Topics

OCRA’s Advocate’s Corner: March 2026

OCRA’s Advocate’s Corner: March 2026

Written by Julia Thayer, Associate Director, Advocacy This month, more than 120 OCRA Advocate Leaders traveled to Washington, DC for Advocacy Day—braving snowstorms, severe weather, and even a partial government shutdown to make their voices heard on Capitol Hill. We kicked things off with a full day of training, where the group built skills, shared stories, and … Continued

Read more

OCRA’s Spring Advocacy Day Brings Impact to Capitol Hill

OCRA’s Spring Advocacy Day Brings Impact to Capitol Hill

On March 17, 122 Advocate Leaders from nearly 40 states and Washington, DC, converged on Capitol Hill for OCRA’s Spring Advocacy Day. Together, they held 158 meetings with Congressional offices, carrying a clear message: Congress must sustain and build on its commitment to ovarian and gynecologic cancer research. The energy and reach of this year’s … Continued

Read more

Cool Hand Frank Names OCRA Featured Cause for March

Cool Hand Frank Names OCRA Featured Cause for March

Cool Hand Frank, a digital publication that spotlights nonprofits making a difference, has named Ovarian Cancer Research Alliance (OCRA) its featured cause for March 2026, spotlighting OCRA’s work in advancing ovarian and gynecologic cancer research and supporting patients and their loved ones. The publication cited a deeply personal connection to the cause, with the author … Continued

Read more

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.